<DOC>
	<DOCNO>NCT02180282</DOCNO>
	<brief_summary>Up 20 healthy subject age 15-45 year old , Skin Phototype I-V , Study conduct 1 site . Primary objective evaluate efficacy IPL acne filter treatment improvement acne vulgaris assess lesion count .</brief_summary>
	<brief_title>Impact M22-IPL Acne Filter Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>1 . Able read , understand provide write Informed Consent ; 2 . Healthy male female , 1545 year age ; 3 . Fitzpatrick skin type IV ; 4 . Have least 15 inflammatory lesion ( papule pustule ) face . 5 . Having clinical diagnosis mild moderate inflammatory acne face Investigator Global Acne scale = 2 3 ; 6 . Able willing comply treatment/followup schedule requirement ; 7 . Women childbearing age require use reliable method birth control ( intrauterine device , birth control pill , condom spermicidal , Nova ring , partner vasectomy abstinence ) least 3 month prior enrollment throughout course study . 1 . Skin type VI ; 2 . Pregnant , intend become pregnant course study , less 3 month postpartum less 6 week completion breastfeeding ; 3 . Heavy smoker ( &gt; 1 pack cigarette day ) ; 4 . Unable unlikely refrain tanning , include use tan booth , course study ; 5 . Photosensitivity sensitivity sun cause rash allergic reaction ; 6 . Use photosensitive medication light exposure contraindicate ; 7 . Treatment topical retinoid therapy antibiotic treatment acne within 2 week study enrollment study . 8 . Treatment oral retinoid medication ( Accutane® Soriatane® ) within 6 month study enrollment study . 9 . Treatment topical systemic anti acne therapy least 2 week prior start study treatment study . 10 . Any history gold therapy ; 11 . Prior use collagen , fat injection method skin augmentation ( enhancement inject implanted material ) treat area within 12 month initial treatment course study . Treatment may perform permanent dermal implant ; 12 . Prior ablative resurfacing procedure face lift treat area laser device within 12 month initial treatment course study ; 13 . Any surgery treat area within 9 month initial treatment course study ; 14 . Participation study another investigational device drug involve anatomical site within 3 month prior enrollment evaluation , involve anatomical site , per Investigator 's discretion ; 15 . History keloid type hypertrophic scar formation poor wound heal previously injure skin area ; 16 . Showing symptoms hormonal disorder , per Investigator 's discretion ( Melasma , Chloasma ) ; 17 . Concurrent inflammatory skin condition , Open laceration abrasion sort area treat course treatment ; 18 . Active Herpes Simplex time treatment experience three episode Herpes Simplex eruption within year study enrollment ; 19 . Having bleed disorder take anticoagulation medication , include heavy use aspirin , manner allow minimum 10 day washout period prior treatment ( per patient 's physician discretion ) ; 20 . History immunosuppression/immune deficiency disorder ( include HIV infection AIDS ) use immunosuppressive medication ; 21 . Having form active cancer time enrollment course study history skin cancer face ; 22 . Mentally incompetent evidence active substance alcohol abuse ; 23 . Any condition , Investigator 's opinion , would make unsafe ( subject study personnel ) treat subject part research study ; 24 . For subject undergoing test spot : considerable undesired response consist skin hypopigmentation ( long term whitening ) , scar pre scar formation response deem Investigator ground exclusion .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Acne Treatment</keyword>
</DOC>